Clinician Management Preferences for Clostridioides difficile Infection in Adults: A 2024 Emerging Infections Network Survey

Overview of attention for article published in Open Forum Infectious Diseases, June 2025

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news: 1 news outlet
bluesky: 5 Bluesky users

podcasts: 1 podcast

Readers on

mendeley: 3 Mendeley

So far, Altmetric has seen 7 Bluesky posts from 5 Bluesky users, with an upper bound of 10,151 followers.

Great work done by one of our former fellows Dr. Noah Boton. Survey of the CDC EIN regarding Cdiff medications. (RIP bezlo ☹️) https://bsky.app/profile/did:plc:6peijvvlgjki2rrxitoa65sv/post/3lsmkj2eood2l

Thank you to @ofidjournal.bsky.social for publishing our team's work. Proud of Dr. Boton for completing one of his many fellowship projects. Shout-out to the EIN and all our team members (including @payalpatel.bsky.social @mmpharmd.bsky.social and sever…

In a survey of 500 ID clinicians, 83% prescribed vancomycin for CDI. Barriers included insurance issues (82%) and limited access to FMT (48%). Bezlotoxumab was available to 74%. #idsky

Retrospective Analysis of the Clinical Significance of Positive Blood Cultures in the Emergency Department: A Single-Center Study ✅ Just Accepted #IDSky

This page shows the most recent Bluesky posts that mention this research output. Click here to find out how to access more activity, including 3 additional Bluesky posts.